VCEL
Price
$40.22
Change
-$0.80 (-1.95%)
Updated
Oct 16, 01:04 PM (EDT)
Capitalization
2.06B
26 days until earnings call
Intraday BUY SELL Signals
VCYT
Price
$43.56
Change
-$0.83 (-1.87%)
Updated
Oct 16, 02:55 PM (EDT)
Capitalization
3.64B
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

VCEL vs VCYT

VCEL vs VCYT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
VCEL vs. VCYT commentary
Oct 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VCEL is a Hold and VCYT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for VCEL with price predictions
Oct 15, 2026

VCEL's RSI Oscillator ascending out of oversold territory

The RSI Indicator for VCEL moved out of oversold territory on September 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 23 of the 30 cases the stock moved higher. This puts the odds of a move higher at 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on VCEL as a result. In 73 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for VCEL just turned positive on September 16, 2026. Looking at past instances where VCEL's MACD turned positive, the stock continued to rise in 39 of 53 cases over the following month. The odds of a continued upward trend are 74%.

Following a +1.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where VCEL advanced for three days, in 212 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

The Aroon Indicator entered an Uptrend today. In 156 of 225 cases where VCEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 67 cases where VCEL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

VCEL broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. VCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.568) is normal, around the industry mean (26.782). P/E Ratio (83.833) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (6.887) is also within normal values, averaging (437.542).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for VCYT with price predictions
Oct 15, 2026

VCYT in upward trend: price rose above 50-day moving average on October 15, 2026

VCYT moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VCYT's RSI Indicator exited the oversold zone, 15 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 66 cases where VCYT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on VCYT as a result. In 74 of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The 10-day moving average for VCYT crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.

Following a +2.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where VCYT advanced for three days, in 202 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VCYT turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 38 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCYT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

VCYT broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VCYT entered a downward trend on September 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating fairly steady price growth. VCYT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.619) is normal, around the industry mean (72.578). P/E Ratio (32.329) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (5.583) is also within normal values, averaging (9.775).

The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCYT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

FUNDAMENTALS RATINGS
VCEL vs VCYT: Fundamental Ratings
VCEL
VCYT
OUTLOOK RATING
1..100
2131
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7875
PRICE GROWTH RATING
1..100
4945
P/E GROWTH RATING
1..100
9798
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for VCEL (89) in the Medical Specialties industry. This means that VCYT’s stock grew somewhat faster than VCEL’s over the last 12 months.

VCYT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VCEL (100) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to VCEL’s over the last 12 months.

VCYT's SMR Rating (75) in the Biotechnology industry is in the same range as VCEL (78) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to VCEL’s over the last 12 months.

VCYT's Price Growth Rating (45) in the Biotechnology industry is in the same range as VCEL (49) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to VCEL’s over the last 12 months.

VCEL's P/E Growth Rating (97) in the Medical Specialties industry is in the same range as VCYT (98) in the Biotechnology industry. This means that VCEL’s stock grew similarly to VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VCELVCYT
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
79%
COMPARISON
Comparison
Oct 16, 2026
Stock price -- (VCEL: $41.02 vs. VCYT: $44.39)
Brand notoriety: VCEL and VCYT are both not notable
VCEL represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: VCEL: 107% vs. VCYT: 90%
Market capitalization -- VCEL: $2.06B vs. VCYT: $3.64B
VCEL [@Biotechnology] is valued at $2.06B. VCYT’s [@Medical Specialties] market capitalization is $3.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Medical Specialties] industry is $20.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VCEL’s FA Score shows that 0 FA rating(s) are green while VCYT’s FA Score has 0 green FA rating(s).

  • VCEL’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VCEL’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 6 bullish TA indicator(s).

  • VCEL’s TA Score: 5 bullish, 3 bearish.
  • VCYT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both VCEL and VCYT are a good buy in the short-term.

Price Growth

VCEL (@Biotechnology) experienced а +2.42% price change this week, while VCYT (@Medical Specialties) price change was +1.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.29%. For the same industry, the average monthly price growth was -16.93%, and the average quarterly price growth was -20.36%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.70%. For the same industry, the average monthly price growth was -4.33%, and the average quarterly price growth was +32.34%.

Reported Earning Dates

VCEL is expected to report earnings on Nov 11, 2026.

VCYT is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-9.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-5.70% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
VCEL
Daily Signal:
Gain/Loss:
VCYT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETHT15.990.29
+1.85%
ProShares Ultra Ether ETF (ETHT)
METL23.600.34
+1.45%
Sprott Active Metals & Miners ETF (METL)
LTPZ46.350.53
+1.16%
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund (LTPZ)
GSX31.16N/A
N/A
Tradr 2X Long GS Daily ETF
TBX29.53-0.19
-0.65%
ProShares Short 7-10 Year Treasury (TBX)